Drug Profile
Research programme: therapeutic vaccines - Provecs Medical
Alternative Names: Im01; Im03; Immunalon®Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Provecs Medical
- Class Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Infections; Solid tumours
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Solid-tumours in Germany (Intratumoural, Injection)
- 16 Jul 2016 No recent reports of development identified for research development in Infections in Germany (Parenteral)
- 31 Dec 2010 Early research in Infections in Germany (Parenteral)